Literature DB >> 29272056

Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.

Daniel Dejaco1, Teresa Steinbichler1, Volker H Schartinger1, Natalie Fischer1, Maria Anegg1, Jozsef Dudas1, Andrea Posch2, Gerlig Widmann3, Herbert Riechelmann1.   

Abstract

BACKGROUND: Tumor volume in head and neck squamous cell carcinoma (HNSCC) was mainly measured in nonsurgically treated patients. We analyzed the influence of tumor volume on complete response (CR), overall survival (OS), and clear surgical margins also in primarily surgically treated patients.
METHODS: In contrast-enhanced CTs, the tumor volumes of patients with incident HNSCC were measured.
RESULTS: The tumor volumes of 259 patients were measured, of which 125 patients (48%) underwent primary surgery and 102 patients (84%) had clear margins. The tumor volume was not an independent factor for CR at the primary tumor site. Risk of death increased by 1.4% per mL of tumor volume (95% confidence interval [CI] 0.8%-2.0%; P < .001). The OS was better in patients treated with primary surgery, if the tumor volume was ≤12 mL (P < .001). Risk of involved margins increased by 4.5% per mL of tumor volume (95% CI 0.9%-8.3%; P = .003). The predicted probability of clear margins was ≥80% in tumor volumes ≤ 16 mL.
CONCLUSION: The tumor volume had an impact on CR, OS, and clear margins. The tumor volume may also aid in selecting HNSCC treatment.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  head and neck squamous cell carcinoma; prognosis; surgical therapy; survival; tumor volume

Mesh:

Year:  2017        PMID: 29272056     DOI: 10.1002/hed.25040

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Polyamine Metabolites as Biomarkers in Head and Neck Cancer Biofluids.

Authors:  Brian C DeFelice; Oliver Fiehn; Peter Belafsky; Constanze Ditterich; Michael Moore; Marianne Abouyared; Angela M Beliveau; D Gregory Farwell; Arnaud F Bewley; Shannon M Clayton; Joehleen A Archard; Jordan Pavlic; Shyam Rao; Maggie Kuhn; Peter Deng; Julian Halmai; Kyle D Fink; Andrew C Birkeland; Johnathon D Anderson
Journal:  Diagnostics (Basel)       Date:  2022-03-24

2.  Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma.

Authors:  Stephanie Flukes; Shivangi Lohia; Christopher A Barker; Jennifer R Cracchiolo; Ian Ganly; Snehal G Patel; Benjamin R Roman; Jatin P Shah; Alexander N Shoushtari; Viviane Tabar; Akash Shah; Marc A Cohen
Journal:  Head Neck       Date:  2020-08-01       Impact factor: 3.147

3.  Specific growth rates calculated from CTs in patients with head and neck squamous cell carcinoma: a retrospective study performed in Austria.

Authors:  Daniel Dejaco; Teresa Steinbichler; Volker Hans Schartinger; Natalie Fischer; Maria Anegg; Joszef Dudas; Andrea Posch; Gerlig Widmann; Herbert Riechelmann
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

4.  The importance of feature aggregation in radiomics: a head and neck cancer study.

Authors:  Pierre Fontaine; Oscar Acosta; Joël Castelli; Renaud De Crevoisier; Henning Müller; Adrien Depeursinge
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

5.  Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma.

Authors:  Oliver Guido Verhoek; Lisa Jungblut; Olivia Lauk; Christian Blüthgen; Isabelle Opitz; Thomas Frauenfelder; Katharina Martini
Journal:  Diagnostics (Basel)       Date:  2022-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.